NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EvolutionaryScale

EvolutionaryScale

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.evolutionaryscale.ai/

Last Round

Seed

Jun 25, 2024

Est. Valuation

$200M

Total Funding Raised

$182M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EvolutionaryScale is a biotechnology company that develops artificial intelligence models to design therapies by predicting protein structures through the integration of biological data, allowing researchers to utilize large language models for creating RNA-based drug therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

generative biologyprotein designfoundation modeldrug discoverysynthetic biologyprotein language modelbio-aifrontier ai labprotein engineeringgenerative aibiological dataai for sciencebiotech aiapi platformusage-based saas

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EvolutionaryScale Comparables

Compare EvolutionaryScale with similar companies based on industry and business-model similarity.

EvolutionaryScale comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anthrogen
89%
Boltz
88%
BioLM
86%

EvolutionaryScale Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 25, 2024
SeedAug 25, 2023

Key People

Founding team and executive leadership

Luuk van Schijndel

Interim CFO

Executive Team

EvolutionaryScale Investors

Notable investors and investment history

EvolutionaryScale investors
InvestorRounds
Lux CapitalSeed
NVenturesSeed
NVenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 57% MoM, reaching 21K.

  • Nov 3, 2025

    Developing AI models for novel protein generation in scientific research.

EvolutionaryScale Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EvolutionaryScale Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EvolutionaryScale's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range20
Year Founded2023
Last FundingJun 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.